This work was supported by the ProRetina Deutschland, Aachen, Germany; the Association of Rhine-Westphalian Ophthalmologists, Recklinghausen, Germany; the German Ophthalmological Society and the German Research Foundation (Grants MU4279/1-1, MU4279/2-1, and GL920/1-1), and the National Institute for Health Research Oxford Biomedical Research Centre. The funding organizations had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Disclosure: P.L. Müller, Heidelberg Engineering (F), Optos (F), Carl Zeiss MedicTec (F), CenterVue (F); J. Birtel, Heidelberg Engineering (F), Optos (F), Carl Zeiss MedicTec (F), CenterVue (F); P. Herrmann, Heidelberg Engineering (F), Optos (F), Carl Zeiss MedicTec (F), CenterVue (F); F.G. Holz, Heidelberg Engineering (F, C, R), Optos (F), Carl Zeiss MedicTec (F, C), CenterVue (F), Allergan (F, R), Alcon/Novartis (F, R), Genentech/Roche (F, R), Bayer (F, R), Acucela (F, R), Boehringer Ingelheim (F, R), LinBioscience (F), Grayburg (F), Nightstar (F); P. Charbel Issa, None; M. Gliem, Heidelberg Engineering (F), Optos (F), Carl Zeiss MedicTec (F), CenterVue (F)